The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Personalized Medicine Bioinformatics Market Across 2026–2030?
The personalized medicine bioinformatics market has seen swift expansion over recent years. Its valuation is anticipated to climb from $3.87 billion in 2025 to $4.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.6%. Historically, this market’s expansion has been fueled by factors including the broader adoption of next-generation sequencing, the increasing supply of genomic datasets, enhanced research funding for precision medicine, a rising imperative for data-driven clinical insights, and progress in bioinformatics algorithms.
The personalized medicine bioinformatics market is projected to experience substantial expansion over the coming years. This market is forecast to reach $7.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.3%. Factors contributing to this growth during the projected period include the growing incorporation of bioinformatics into clinical processes, increased funding for personalized medicine initiatives, the broadening of AI-powered clinical decision support, a rise in the uptake of population-scale genomics analysis, and an escalating need for interoperable health data platforms. Key trends anticipated during the forecast timeframe encompass a greater embrace of AI-powered genomic data analytics, the increasing utilization of multi-omics data integration platforms, a rising requirement for cloud-based bioinformatics solutions, the development of pharmacogenomic decision support instruments, and a heightened emphasis on scalable data interpretation frameworks.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28294&type=smp
What Primary Drivers Are Shaping The Development Of The Personalized Medicine Bioinformatics Market?
The increasing need for personalized medicine is anticipated to boost the expansion of the personalized medicine bioinformatics market in the future. Personalized medicine defines a medical strategy that tailors prevention, diagnosis, and therapeutic interventions according to an individual’s unique genetic composition, health status, and lifestyle factors. This field is expanding thanks to breakthroughs in genomics and data analytics, which facilitate precise genetic profiling, leading to more accurate treatments, better patient outcomes, and less trial-and-error. Personalized medicine bioinformatics plays a crucial role by analyzing genomic and clinical data to uncover insights into specific health conditions, thereby aiding in precise treatment selections, predicting drug responses, and guiding targeted therapies to improve customized patient care. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care organization, reported that the FDA sanctioned 16 novel personalized treatments for rare disease patients in 2023, marking an increase from six in 2022. Consequently, the rising demand for personalized medicine is fueling the growth of the personalized medicine bioinformatics market.
What Segmentation Levels Are Considered In The Personalized Medicine Bioinformatics Market?
The personalized medicine bioinformatics market covered in this report is segmented –
1) By Technology: Gene Sequencing, Pharmacogenomics, Microarray Technology, Artificial Intelligence-Driven Analytics Platforms, Other Technologies
2) By Application: Genomics, Proteomics, Transcriptomics, Metabolomics, Epigenomics, Other Applications
3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Diagnostics Laboratories, Hospitals And Academic Medical Centers, Contact Research Organizations and Biobanks, Other End-Users
Subsegments:
1) By Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Single-Molecule Real-Time Sequencing (SMRT), Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS)
2) By Pharmacogenomics: Drug-Gene Interaction Analysis, Adverse Drug Reaction (ADR) Prediction, Biomarker Discovery, Personalized Drug Response Profiling
3) By Microarray Technology: DNA Microarray, RNA Microarray, Protein Microarray, Comparative Genomic Hybridization (CGH) Microarray
4) By Artificial Intelligence-Driven Analytics Platforms: Machine Learning-Based Platforms, Deep Learning-Based Platforms, Natural Language Processing (NLP) Platforms, Predictive Analytics Platforms, Clinical Decision Support Systems (CDSS)
5) By Other Technologies: Proteomics Analysis, Metabolomics Analysis, Epigenomics Profiling, Bioinformatics Cloud Platforms
What Key Trends Are Influencing The Development Of The Personalized Medicine Bioinformatics Market?
Major companies operating within the personalized medicine bioinformatics market are concentrating on developing advanced solutions, such as predictive analytics platforms, to improve disease prediction and enhance patient outcomes. A predictive analytics platform employs machine learning, algorithms, and statistical models to analyze historical and real-time data for forecasting results, enabling healthcare providers to anticipate risks, refine treatments, and make proactive decisions. For instance, in April 2023, Certis Oncology Solutions, a US-based biotechnology company, unveiled CertisAI, a predictive analytics platform. This AI/ML-based platform harnesses big data, statistical algorithms, and machine learning to predict drug efficacy based on gene expression biomarkers, aiming to accelerate drug discovery and the development of companion diagnostics in precision oncology. The platform is currently validating its proprietary approach to predicting therapeutic response and supporting its use as a service accessible to biopharmaceutical companies for improved early drug development decisions and personalized cancer treatment strategies.
Which Leading Firms Are Contributing To The Growth Of The Personalized Medicine Bioinformatics Market?
Major companies operating in the personalized medicine bioinformatics market are F. Hoffmann-La Roche AG, Merck KGaA Darmstadt Germany, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., Guardant Health Inc., Sophia Genetics SA, DNAnexus Inc., Deep Genomics Inc., Congenica Ltd, Phase Genomics Inc., Analome Inc., Pluto Bioinformatics Inc., BioBam Bioinformatics S.L., OncoBox Inc.
Read the full personalized medicine bioinformatics market report here:
How Does The Personalized Medicine Bioinformatics Market Perform Across Major Global Regions?
North America was the largest region in the personalized medicine bioinformatics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized medicine bioinformatics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Personalized Medicine Bioinformatics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28294&type=smp
Browse Through More Reports Similar to the Global Personalized Medicine Bioinformatics Market 2026, By The Business Research Company
Personalized Nutrition Global Market Report
https://www.thebusinessresearchcompany.com/report/personalized-nutrition-global-market-report
Next Generation Personalized Beauty Global Market Report
Artificial Intelligence Ai Based Personalization Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
